Hello, Fool! | Login | Signup | My Fool
Oct 15, 2008 6:30 PM ET | Feedback | Site Changes | Help
The Company currently offers four software products for pharmaceutical research: ADMET Predictor/ ADMET Modeler, ClassPharmer, DDDPlus, and GastroPlus.
View Ticker Page (SLP)
Results 1 - 4 of 4 : 1
Recs
billbu (98.61) Submitted: 9/11/07 1:59 PM : Start Price: $6.30 SLP Score: -44.30
SLP's primary business is developing and producing best in class molecular modeling software for pharmaceutical discovery and development. The ability to predict the properties of proposed molecules allows researchers to avoid wasting time and resour...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
darkgoody (58.48) Submitted: 11/26/07 12:36 PM : Start Price: $5.58 SLP Score: -43.80
Lots of room for industry consolidation and decent cash-on-hand to explore acquisitions. Organic growth will continue and execution of acquisition strategy should make this a multibagger. Buy under $5.
doublet83 (36.70) Submitted: 9/25/07 6:34 PM : Start Price: $8.50 SLP Score: 46.35
Market overestimating the addressable market of their product. Valuation can only be justified if historical growth rates are sustained for a significant period of time, but these growth rates are clearly unsustainble.
wolfofwallstreet (83.67) Submitted: 9/05/07 6:23 PM : Start Price: $6.74 SLP Score: -45.28
Impressive revenue growth. Since the same quarter one year prior, revenues leaped by 71.0%.Earnings growth of 133.33% and other important driving factors, SLP has surged by 254.89% over the past year, outperforming the rise in the S&P 500 Index duri...